Bausch Health Companies Inc. Stock Issued During Period, Shares, New Issues
Bausch Health Companies Inc. (BHC) had Stock Issued During Period, Shares, New Issues of 213.61 thousand shares as of 2016-06-10, per its 10-Q filed 2016-11-09.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2018-08-10
- 2016-06-10: Stock Issued During Period, Shares, New Issues 213.61K shares.
- 2015-03-27: Stock Issued During Period, Shares, New Issues 7.29M shares.
- 2013-06-24: Stock Issued During Period, Shares, New Issues 27.06M shares; Stock Issued During Period, Shares, New Issues 0 month 27.06M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 0 month |
|---|---|---|
| 2016-06-10 | 213.61K shares 10-Q · filed 2016-11-09 | |
| 2015-03-27 | 7.29M shares 8-K · filed 2018-08-10 | |
| 2013-06-24 | 27.06M shares 10-K · filed 2016-04-29 | 27.06M shares 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |